title: Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing.
abstract: The striatum receives prominent dopaminergic innervation that is integral to appetitive learning, performance, and motivation. Signaling through the dopamine D2 receptor is critical for all of these processes. For instance, drugs with high affinity for the D2 receptor potently alter timing of operant responses and modulate motivation. Recently, in an attempt to model a genetic abnormality encountered in schizophrenia, mice were generated that reversibly overexpress D2 receptors specifically in the striatum (Kellendonk et al., 2006). These mice have impairments in working memory and behavioral flexibility, components of the cognitive symptoms of schizophrenia, that are not rescued when D2 overexpression is reversed in the adult. Here we report that overexpression of striatal D2 receptors also profoundly affects operant performance, a potential index of negative symptoms. Mice overexpressing D2 exhibited impairments in the ability to time food rewards in an operant interval timing task and reduced motivation to lever press for food reward in both the operant timing task and a progressive ratio schedule of reinforcement. The motivational deficit, but not the timing deficit, was rescued in adult mice by reversing D2 overexpression with doxycycline. These results suggest that early D2 overexpression alters the organization of interval timing circuits and confirms that striatal D2 signaling in the adult regulates motivational process. Moreover, overexpression of D2 under pathological conditions such as schizophrenia and Parkinson's disease could give rise to motivational and timing deficits.
authors.affiliation: Division of Integrative Neuroscience, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA. mrd28@columbia.edu
authors.forename: Michael R
authors.initials: MR
authors.lastname: Drew
authors.forename: Eleanor H
authors.initials: EH
authors.lastname: Simpson
authors.forename: Christoph
authors.initials: C
authors.lastname: Kellendonk
authors.forename: William G
authors.initials: WG
authors.lastname: Herzberg
authors.forename: Olga
authors.initials: O
authors.lastname: Lipatova
authors.forename: Stephen
authors.initials: S
authors.lastname: Fairhurst
authors.forename: Eric R
authors.initials: ER
authors.lastname: Kandel
authors.forename: Chara
authors.initials: C
authors.lastname: Malapani
authors.forename: Peter D
authors.initials: PD
authors.lastname: Balsam
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001070:Appetitive Behavior / Q000502:physiology; D001522:Behavior, Animal; D003216:Conditioning, Operant / Q000502:physiology*; D003342:Corpus Striatum / Q000378:metabolism*; D004318:Doxycycline / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D017403:In Situ Hybridization / Q000379:methods; D007859:Learning Disabilities / Q000235:genetics; D008433:Mathematics; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009042:Motivation; D017448:Receptors, Dopamine D2 / Q000235:genetics / Q000378:metabolism*; D012055:Reinforcement Schedule; D012054:Reinforcement, Psychology; D013997:Time Factors
chemical_list: D017448:Receptors, Dopamine D2; D000110:Acetylcholinesterase; D004318:Doxycycline